Literature DB >> 27394974

Findings of an observational investigation of pure remote follow-up of pacemaker patients: is the in-clinic device check still needed?

D Facchin1, M S Baccillieri2, G Gasparini3, F Zoppo4, G Allocca5, M Brieda6, R Verlato2, A Proclemer7.   

Abstract

BACKGROUND: Device follow-up is mandatory in the care of patients with a pacemaker. However, in most cases, device checks appear to be mere technical, time-consuming procedures. The aim of this research is to evaluate whether remote follow-up can replace in-clinic device checks by assessing clinical outcomes for pacemaker patients followed only via remote follow-up. METHODS AND
RESULTS: Consecutive pacemaker patients followed with remote monitoring were prospectively included by 6 Italian cardiology centers in an observational investigation. The workflow for remote monitoring included an initial assessment by nursing staff and, when necessary, by a responsible physician for medical decisions. No in-person visits were scheduled after the start of remote monitoring. One-thousand and two-hundred and fifty one patients (30% female, 75±11years old) were followed for a median observation period of 15months. Out of 4965 remote transmissions, 1882 (38%) had at least one clinically relevant event to be investigated further, but, only after 137 transmissions (2.8%), the patients were contacted for an in-clinic visit or hospitalization. Sixty-nine patients died and 124 were hospitalized for various reasons. Atrial fibrillation episodes were the most common clinical events discovered by remote transmissions, occurring in 1339 (26%) transmissions and 471 (38%) patients.
CONCLUSIONS: Our experience shows that remote monitoring in a pacemaker population can safely replace in-clinic follow-up, avoiding unnecessary in-hospital device follow-up.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Pacemakers; Remote follow-up; Remote interrogation; Remote monitoring

Mesh:

Year:  2016        PMID: 27394974     DOI: 10.1016/j.ijcard.2016.06.162

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Organizational model and reactions to alerts in remote monitoring of cardiac implantable electronic devices: A survey from the Home Monitoring Expert Alliance project.

Authors:  Gabriele Zanotto; Antonio D'Onofrio; Paolo Della Bella; Francesco Solimene; Ennio C Pisanò; Saverio Iacopino; Cristina Dondina; Daniele Giacopelli; Alessio Gargaro; Renato P Ricci
Journal:  Clin Cardiol       Date:  2018-12-15       Impact factor: 2.882

2.  Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE).

Authors:  Francisco Javier García-Fernández; Joaquín Osca Asensi; Rafael Romero; Ignacio Fernández Lozano; José María Larrazabal; José Martínez Ferrer; Raquel Ortiz; Marta Pombo; Francisco José Tornés; Mehrard Moradi Kolbolandi
Journal:  Eur Heart J       Date:  2019-06-14       Impact factor: 29.983

3.  Outsourcing the Remote Management of Cardiac Implantable Electronic Devices: Medical Care Quality Improvement Project.

Authors:  Gabriele Giannola; Riccardo Torcivia; Riccardo Airò Farulla; Tommaso Cipolla
Journal:  JMIR Cardio       Date:  2019-12-18

4.  Cost-utility analysis of telemonitoring versus conventional hospital-based follow-up of patients with pacemakers. The NORDLAND randomized clinical trial.

Authors:  Antonio Lopez-Villegas; Daniel Catalan-Matamoros; Salvador Peiro; Knut Tore Lappegard; Remedios Lopez-Liria
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

5.  Prognostic role of non-sustained ventricular tachycardia detected with remote interrogation in a pacemaker population.

Authors:  Stefano Poli; Domenico Facchin; Francesca Rizzetto; Luca Rebellato; Elisabetta Daleffe; Mauro Toniolo; Antonella Miconi; Alessandro Altinier; Corrado Lanera; Stefano Indrigo; Jennifer Comisso; Alessandro Proclemer
Journal:  Int J Cardiol Heart Vasc       Date:  2019-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.